|
1
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age, State
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nau JY: New techniques in bone and joint
imaging (2). Rev Med Suisse. 1:6512005.(In French). PubMed/NCBI
|
|
3
|
Klein MJ and Siegal GP: Osteosarcoma:
Anatomic and histologic variants. Am J Clin Pathol. 125:555–581.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hawkins DS and Arndt CA: Pattern of
disease recurrence and prognostic factors in patients with
osteosarcoma treated with contemporary chemotherapy. Cancer.
98:2447–2456. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu PK, Chen WM, Chen CF, Lee OK, Haung CK
and Chen TH: Primary osteogenic sarcoma with pulmonary metastasis,
Clinical results and prognostic factors in 91 patients. Jpn J Clin
Oncol. 39:514–522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tan ML, Choong PF and Dass CR:
Osteosarcoma. Conventional treatment vs. Histopathology. Cancer
Biol Ther. 8:106–117. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Simpson AJ, Caballero OL, Jungbluth A,
Chen YT and Old LJ: Cancer/testis antigens, gametogenesis and
cancer. Nat Rev Cancer. 5:615–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zendman AJ, Ruiter DJ and Van Muijen GN:
Cancer/testis-associated, genes. Identification, expression profile
and putative function. J Cell Physiol. 194:272–288. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jagadish N, Rana R, Selvi R, Mishra D,
Garg M, Yadav S, Herr JC, Okumura K, Hasegawa A, Koyama K and Suri
A: Characterization of a novel human sperm-associated antigen 9
(SPAG9) having structural homology with c-Jun N-terminal
kinase-interacting protein. Biochem J. 389:73–82. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jagadish N, Rana R, Mishra D, Kumar M and
Suri A: Sperm associated antigen 9 (SPAG9): A new member of c-Jun
NH2 -terminal kinase (JNK) interacting protein exclusively
expressed in testis. Keio J Med. 54:66–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garg M, Chaurasiya D, Rana R, Jagadish N,
Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, et al:
Sperm-associated antigen 9, a novel cancer testis antigen, is a
potential target for immunotherapy in epithelial ovarian cancer.
Clin Cancer Res. 13:1421–1428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garg M, Kanojia D, Khosla A, Dudha N, Sati
S, Chaurasiya D, Jagadish N, Seth A, Kumar R, Gupta S, et al:
Sperm-associated antigen 9 is associated with tumor growth,
migration and invasion in renal cell carcinoma. Cancer Res.
68:8240–8248. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sinha A, Agarwal S, Parashar D, Verma A,
Saini S, Jagadish N, Ansari AS, Lohiya NK and Suri A: Down
regulation of SPAG9 reduces growth and invasive potential of
triple-negative breast cancer cells, Possible implications in
targeted therapy. J Exp Clin Cancer Res. 32:692013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Volard B, Krieger S, Planchard G, Hardouin
A, Vaur D, Rame JP and Bardet S: Assessment of SPAG9 transcript in
fine needle aspirates of thyroid nodules. Eur Thyroid J. 1:118–121.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanojia D, Garg M, Gupta S, Gupta A and
Suri A: Sperm-associated antigen 9 is a novel biomarker for
colorectal cancer and is involved in tumor growth and
tumorigenicity. Am J Pathol. 178:1009–1020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Dong Q, Miao Y, Fu L, Lin X and
Wang E: Clinical significance and biological roles of SPAG9
overexpression in non-small cell lung cancer. Lung Cancer.
81:266–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanojia D, Garg M, Gupta S, Gupta A and
Suri A: Sperm-associated antigen 9, a novel biomarker for early
detection of breast cancer. Cancer Epidemiol Biomarkers Prev.
18:630–639. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Garg M, Kanojia D, Suri S and Suri A:
Small interfering RNA-mediated down-regulation of SPAG9 inhibits
cervical tumor growth. Cancer. 115:5688–5699. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Burks DJ, Carballada R, Moore HD and
Saling PM: Interaction of a tyrosine kinase from human sperm with
the zona pellucida at fertilization. Science. 269:83–86. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luconi M, Krausz C, Forti G and Baldi E:
Extracellular calcium negatively modulates tyrosine phosphorylation
and tyrosine kinase activity during capacitation of human
spermatozoa. Biol Reprod. 55:207–216. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Garg M, Kanojia D, Salhan S, Suri S, Gupta
A, Lohiya NK and Suri A: Sperm-associated antigen 9 is a biomarker
for early cervical carcinoma. Cancer. 115:2671–2683. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hynes RO: Metastatic potential: Generic
predisposition of the primary tumor or rare metastatic variants-or
both? Cell. 113:821–823. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Halbersztadt A, Haloń A, Pajak J,
Robaczynski J, Rabczynski J and St Gabryś M: The role of matrix
metalloproteinases in tumor invasion and metastasis. Ginekol Pol.
77:63–71. 2006.(In Polish). PubMed/NCBI
|
|
25
|
Zhang XY, Hong BF, Chen GF, Lu YL and
Zhong M: Significance of MMP2 and MMP9 expression in prostate
cancer. Zhonghua Nan Ke Xue. 11:359–361. 2005.(In Chinese).
PubMed/NCBI
|
|
26
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weidner N: Intratumor microvessel density
as a prognostic factor in cancer. Am J Pathol. 147:9–19.
1995.PubMed/NCBI
|
|
28
|
Czubayko F, Schulte AM, Berchem GJ and
Wellstein A: Melanoma angiogenesis and metastasis modulated by
ribozyme targeting of the secreted growth factor pleiotrophin. Proc
Natl Acad Sci USA. 93:14753–14758. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Folkman J: Tumor angiogenesis: T
herapeutic implications. N Engl J Med. 285:1182–1186. 1971.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao YEG, Wang E, Pal K, Dutta SK, Bar-Sagi
D and Mukhopadhyay D: VEGF exerts an angiogenesis-independent
function in cancer cells to promote their malignant progression.
Cancer Res. 72:3912–3918. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie K, Wei D, Shi Q and Huang S:
Constitutive and inducible expression and regulation of vascular
endothelial growth factor. Cytokine Growth Factor Rev. 15:297–324.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pal S, Datta K and Mukhopadhyay D: Central
role of p53 on regulation of vascular permeability factor/vascular
endothelial growth factor (VPF/VEGF) expression in mammary
carcinoma. Cancer Res. 61:6952–6957. 2001.PubMed/NCBI
|
|
33
|
Guma M, Rius J, Duong-Polk KX, Haddad GG,
Lindsey JD and Karin M: Genetic and pharmacological inhibition of
JNK ameliorates hypoxia-induced retinopathy through interference
with VEGF expression. Proc Natl Acad Sci USA. 106:8760–8765. 2009.
View Article : Google Scholar : PubMed/NCBI
|
